43
Participants
Start Date
November 30, 2011
Primary Completion Date
October 31, 2015
Study Completion Date
May 31, 2017
Sorafenib Plus Capecitabine (SorCape)
Sorafenib 200-400 mg PO twice daily on days 1-21 (dose escalation schema) plus Capecitabine 1000 mg/m2 PO twice daily on days 1-14 repeated every 21 days
UF Health Cancer Center, Gainesville
Collaborators (1)
Bayer
INDUSTRY
University of Florida
OTHER